• Date: March 3 2025
  • Location: London, England

Attending World ADC Event Series in London next month? Us too!

TAPI is proud to be a trusted partner in advancing the antibody-drug conjugate (ADC) field. With over 85 years of expertise and cutting-edge capabilities, we are one of the few CDMOs 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝘀𝘂𝗽𝗽𝗼𝗿𝘁𝗶𝗻𝗴 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀 𝘄𝗶𝘁𝗵 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹-𝘀𝗰𝗮𝗹𝗲 𝗽𝗮𝘆𝗹𝗼𝗮𝗱 𝗮𝗻𝗱 𝗹𝗶𝗻𝗸𝗲𝗿 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗔𝗗𝗖𝘀.

Our High Potent APIs (OEB6) and tailored solutions help ensure your ADC projects progress seamlessly from development to commercialization.

Let’s explore how we can collaborate to maximize therapeutic success!